Opti Cal/Mag 2:1
Natural health product licensed in Canada
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN or DIN-HM
- 80104948
- Status
- Active licence
- Licence date
- 7 October 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Diglycinate de calcium | 175 mg | 350,000 µg |
| Calcium Source : Calcium carbonate | 175 mg | 350,000 µg |
| Calcium Source : Citrate malate de calcium | 175 mg | 350,000 µg |
| Magnésium Source : Citrate de magnésium | 87.5 mg | 175,000 µg |
| Magnésium Source : Oxyde de magnésium | 87.5 mg | 175,000 µg |
| Magnésium Source : Bisglycinate de magnésium | 87.5 mg | 175,000 µg |
| 1-Carboxy-N,N,N-chlorure de triméthylméthanaminium Source : Chlorhydrate de bétaine | 15 mg | Not calculated |
| Acide L-glutamique Source : Acide glutamique | 15 mg | Not calculated |
| Zinc Source : Diglycinate de zinc | 3 mg | 6,000 µg |
| Vitamine D Source : Cholécalciférol | 100 UI | 5 µg |
| Drynaria fortunei Source : Racine | 0.5 mg | Not calculated |
| Vitamine C Source : Palmitate d'ascorbyle | 0.04 mg | 80 µg |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 0.1 mg | Not calculated |
| mono ester phosphorique phosphohydrolase Source : Aspergillus niger - En entier | 0.1 mg | Not calculated |
Non-medicinal ingredients
Silice, Maltodextrine, Hypromellose, Acide D-malique, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Helps (to) maintain/support immune function. Helps in connective tissue formation. Helps in energy metabolism, tissue formation and bone development. Helps in the development and maintenance of bones and teeth. Helps in the development and maintenance of bones and teeth and maintain proper muscle function and tissue formation. Helps in tissue formation. Helps maintain healthy skin and connective tissue formation. Helps maintain proper muscle function and tissue formation. Helps support bone health. Helps to build strong bones and teeth. Helps to maintain (proper) muscle function. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain healthy skin. Helps to maintain normal electrolyte balance. Helps to maintain proper muscle function, including the heart muscle. Helps with immune function. Maintains healthy hair, skin and nails. Provides/Source of/An electrolyte (for the maintenance of good health). Helps in the development and maintenance of bones and teeth (especially in young adults).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80104948
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.